Overall result forecast presentation:	no
Quantity performed reporting year:	172
Quantity forecast year:	0
Examination by state associations?	no
Exemption?	no
Result of the examination by the federal state authorities?	no
Transitional arrangement?	no

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Compliance with staffing requirements

Clarifying chat completed: no
Clarifying chat not completed: no
No participation in clarifying chat: no
Notification of non-fulfilment of nursing care not made: no

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
42	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
33	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
33	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

General information

Protection concept against (sexual) violence against children and young people

Advice on prevention and intervention in cases of violence and abuse

According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.

Is a protection concept in place? No
No care for children and young people

Commentary on the protection concept

Gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie haben sich Einrichtungen, die Kinder und Jugendliche versorgen, gezielt mit der Prävention von und Intervention bei (sexueller) Gewalt und Missbrauch bei Kindern und Jugendlichen zu befassen (Risiko- und Gefährdungsanalyse) und – der Größe und Organisationsform der Einrichtung entsprechend – konkrete Schritte und Maßnahmen abzuleiten (Schutzkonzept). In diesem Abschnitt geben Krankenhäuser, die Kinder und Jugendliche versorgen, an, ob sie gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie ein Schutzkonzept gegen (sexuelle) Gewalt bei Kindern und Jugendlichen aufweisen.

Drug therapy safety

Steering committee

Drug commission

Training of employees on AMTS related topics

Use of standardised forms for drug medical history

Medikamentenumsetzung

19.09.2013

Provision of one or more electronic drug information systems (e.g. Lauer-Taxe®, ifap klinikCenter®, Gelbe Liste®, Fachinfo-Service®)

Concepts for ensuring the error-free preparation of medications

Bereitstellung einer geeigneten Infrastruktur zur Sicherstellung einer fehlerfreien Zubereitung
Zubereitung durch pharmazeutisches Personal
Anwendung von gebrauchsfertigen Arzneimitteln bzw. Zubereitungen

Electronic support for the supply of patients with drugs

Web-Shop, elektronische Arzneimittelliste, MMI Pharmaindex, Zensy Arztmodul, Intranet

Measures to minimise medication errors

Fallbesprechungen
Maßnahmen zur Vermeidung von Arzneimittelverwechslung
Spezielle AMTS-Visiten (z. B. pharmazeutische Visiten, antibiotic stewardship, Ernährung)
Teilnahme an einem einrichtungsübergreifenden Fehlermeldesystem (siehe Kapitel 12.2.3.2)
Verschiedene Arbeitskreise: Ernährung, Antibiotika, Wundmanagement

Instruments and measures

The instruments and measures to promote drug therapy safety are presented with a focus on the typical procedures of the medication process in inpatient patient care. A special feature of the medication process in the inpatient environment is the transition management during admission and discharge. The instruments and measures listed below address structural elements, e.g. special IT equipment and work materials, as well as process aspects, such as work descriptions for particularly risky process steps or concepts for securing typical risk situations . In addition, proven measures to avoid or learn from medication errors can be specified. The hospital presents here which aspects it has already dealt with and which measures it has specifically implemented. The following aspects can be presented, if necessary using free text fields:
- Admission to hospital, including anamnesis
; Instruments and measures are presented for determining the old medication (drug history), the subsequent clinical assessment and the switch to the medication available in the hospital (house list), as well as for documenting both the patient's original medication and that for hospital treatment adapted medication.
- Medication process in the hospital
In this context, the following sub-processes are assumed as examples: drug history - prescription - patient information - drug delivery - drug use - documentation - therapy monitoring - result assessment. Instruments and measures for safe medication prescription can be presented, e.g. B. in terms of readability, clarity and completeness of the documentation, but also in terms of area of application, effectiveness, benefit-risk ratio, tolerability (including potential contraindications, interactions, etc.) and resource considerations. Information can also be provided to support reliable medication ordering, delivery and use or administration.
- Discharge
In particular, the measures taken by hospitals can be presented to ensure that information on drug therapy is structured and passed on to doctors and physicians providing further treatment, as well as the appropriate provision of patients with drug information, medication plans and medications. Drug prescriptions are made.

AMTS is the totality of measures to ensure an optimal medication process with the aim of reducing medication errors and thus avoidable risks for patients during drug therapy. A prerequisite for the successful implementation of these measures is that AMTS is practised as an integral part of daily routine in an interdisciplinary and multi-professional approach.

Special instrument-based equipment

Research & teaching

Job

FL03 - Student training (clinical traineeship / internship year)

Explanation

Training

Training in other healing professions

HB01 - Nurse and health care worker (m/f)

Comment

HB07 - Surgical technical assistant (m/f)

Comment

HB13 - Medical technical assistant for functional diagnostics (MTAF) (m/f)

Comment

HB15 - Anaesthesia technical assistant (m/f)

Comment

HB18 - Emergency paramedics (m/f) (training period 3 years)

Comment

HB03 - Physical therapist / physiotherapist (m/f)

Comment

Praktikumsplätze im Rahmen der Ausbildung

HB20 - Nursing professional B. Sc.

Comment

Hospital staff
Pharmaceutical personnel
- Explanations: Das Westallgäu Klinikum ist an die zentral Apotheke der Oberschwabenkliniken gGmbH mit Sitz im St. Elisabethenklinikum angegliedert. Bei Bedarf kann jederzeit auf Personal bzw. Konsile zurückgegriffen werden.

Service contact persons

Patient advocates

Clemens Moll

Patientenfürsprecher

Am Engelberg 29
88239 Wangen im Allgäu

Phone: 07520 -950-11
Mail: ed.lleztma@llom.snemelc

Customer feedback management

Sylvia Strick

Beschwerdemanagement

Am Engelberg 29
88239 Wangen im Allgäu

Phone: 0751 -87-3067
Mail: ed.kinilknebawhcsrebo@edrewhcseb

Quality management

Prof. Dr. med. Oliver Adolph

Geschäftsführer für den Bereich Unternehmensentwicklung Medizin und Pflege

Am Engelberg 29
88239 Wangen im Allgäu

Phone: 0751 -87-2080
Mail: ed.kinilknebawhcsrebo@gnurheufstfeahcseg

Diplom-Kaufmann (FH) Jörg Holitschke

Leitung Qualitäts- und Risikomanagement

Am Engelberg 29
88239 Wangen im Allgäu

Phone: 49751872087 -87-2080
Mail: ed.kinilknebawhcsrebo@ekhcstiloH.greoJ

Hygiene officer

Prof. Dr. med. Oliver Adolph

Geschäftsführer für den Bereich Unternehmensentwicklung Medizin und Pflege

Am Engelberg 29
88239 Wangen im Allgäu

Phone: 0751 -87-2080
Mail: ed.kinilknebawhcsrebo@gnurheufstfeahcseg

Prof. Dr. med. Oliver Rentzsch

Geschäftsführer

Am Engelberg 29
88239 Wangen im Allgäu

Phone: 0751 -87-2080
Mail: ed.kinilknebawhcsrebo@gnurheufstfeahcseg

Responsible for drug therapy

Dr. Jörg Bickeböller-Friedrich

Leitung Apotheke

Am Engelberg 29
88239 Wangen im Allgäu

Phone: 0751 -87-2540
Mail: ed.kinilknebawhcsrebo@hcirdeirf-relleobekcib.greoj

Accessibility Officer

Bartels Jutta

Sozialberatung

Am Engelberg 29
88239 Wangen im Allgäu

Phone: 07522 -96-1207
Mail: ed.kinilknebawhcsrebo@negnaW-gnutareblaizoS

Company

General contact details of the hospital

Am Engelberg 29
88239 Wangen im Allgäu

Phone: 07522-960
Fax: 0751-987-2095
Mail: ed.kinilknebawhcsrebo@ofni

Nursing service management

Dr. med. Jan-Ove Faust

Direktor Medizin und Pflege bis 31.07.20

Am Engelberg 29
88239 Wangen im Allgäu

Phone: 0751 -87-2080
Mail: ed.kinilknebawhcsrebo@gnurheufstfeahcseg

Sven Wendt

Leitung Prozess- und Pflegemanagement (LPPM)

Am Engelberg 29
88239 Wangen im Allgäu

Phone: 0751 -87-2080
Mail: ed.kinilknebawhcsrebo@gnurheufstfeahcseg

Head of administration

Jörg Hempel

1. Stellvertretender Geschäftsführer, Direktor Finanzen, Personal und Allgemeine Verwaltung bis 30.06.20

Am Engelberg 29
88239 Wangen im Allgäu

Phone: 0751 -87-2080
Mail: ed.kinilknebawhcsrebo@gnurheufstfeahcseg

Michael Schüler

Geschäftsführer, Direktor Finanzen, Personal und Allgemeine Verwaltung

Am Engelberg 29
88239 Wangen im Allgäu

Phone: 0751 -87-2080
Mail: ed.kinilknebawhcsrebo@gnurheufstfeahcseg

Ulrich Hornstein

Kaufmännischer Direktor

Am Engelberg 29
88239 Wangen im Allgäu

Phone: 0751 -87-2080
Mail: ed.kinilknebawhcsrebo@gnurheufstfeahcseg

Responsible for the quality report in the hospital management

Dr. med. Sebastian Wolf

Geschäftsführer

Am Engelberg 29
88239 Wangen im Allgäu

Phone: 0751 -87-2082
Mail: ed.kinilknebawhcsrebo@gnurheufstfeahcseg

Prof. Dr. Oliver Adolph

Geschäftsführer

Am Engelberg 29
88239 Wangen im Allgäu

Phone: 0751 -87-2082
Mail: ed.kinilknebawhcsrebo@gnurheufstfeahcseg

Ulrich Hornstein

Kaufmännischer Direktor

Am Engelberg 29
88239 Wangen im Allgäu

Phone: 0751 -87-0
Mail: ed.kinilknebawhcsrebo@gnurheufstfeahcseg

Medical management

Prof. Dr. med. Oliver Adolph

Geschäftsführer für den Bereich Unternehmensentwicklung Medizin und Pflege sein 01.06.20

Am Engelberg 29
88239 Wangen im Allgäu

Phone: 0751 -87-2080
Mail: ed.kinilknebawhcsrebo@gnurheufstfeahcseg

Dr. med. Jan-Ove Faust

Direktor Medizin und Pflege bis 31.07.20

Am Engelberg 29
88239 Wangen im Allgäu

Phone: 0751 -87-2080
Mail: ed.kinilknebawhcsrebo@gnurheufstfeahcseg

Prof. Dr. med. Oliver Rentzsch

Ärztlicher Direktor

Am Engelberg 29
88239 Wangen im Allgäu

Phone: 0751 -87-2080
Mail: ed.kinilknebawhcsrebo@gnurheufstfeahcseg

Regional care obligation for psychiatry?

IK number

IK: 260840949

More IK: 260840949

Location number

Location number: 773107000

Old location number: 773107000

Hospital portrait for download